Boston Scientific said Monday it will pay medical device rival Johnson & Johnson $1.73 billion to settle several seven-year-old patent disputes over drug-coated stents. Boston Scientific will pay Johnson & Johnson's Cordis unit $1 billion this week and $725 million next January. The settlement resolves three patent disputes dating back to 2003, and avoids jury trials that were scheduled to begin later this month.
February 02, 2010 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Boston Scientific said Monday it will pay medical device rival Johnson and Johnson $1.73 billion to settle several seven-year-old patent disputes over drug-coated stents.
Boston Scientific will pay Johnson & Johnson’s Cordis unit $1 billion this week and $725 million next January. The settlement resolves three patent disputes dating back to 2003, and avoids jury trials that were scheduled to begin later this month.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
